Discover why Denali Therapeutics Inc. earns a Strong Buy with FDA-priority drugs, solid pipeline, and a strong cash position.

The field of dermatology has witnessed remarkable progress in the prevention and treatment of skin diseases over the past ...

The FDA has placed a hold on Denali Therapeutics’ plans to launch a phase 1 rare disease trial, citing concerns about immune ...

Nicotine addiction remains one of the most persistent public health challenges worldwide, driven by changes in the brain that ...

"Most of the studies on nicotine addiction traditionally focus on neurons, while neglecting the role of glial cells. Our innovative study demonstrates that astrocytes interact with neurons within the ...

DigestMate (TM) became available to health care practitioners in May 2025 through Microbiome Labs' authorized practitioner network. Beginning Dec. 1, 2025, DigestMate (TM) is available on Amazon. For ...

The global enzyme protectants market is projected to reach USD 1,511.5 million by 2035, rising from USD 820.5 million in 2025 ...

The global wine enzymes market is poised for robust growth, with an estimated valuation of USD 1.5 billion in 2025. The market is projected to reach USD 2.4 billion by 2035, registering a compound ...

DES MOINES, IOWA – Kemin Industries has acquired CJ Youtell Biotech, the enzymes and fermentation subsidiary of CJ Bio, Seoul, South Korea. Des Moines-based Kemin now owns CJ Youtell’s fermentation ...

Chapter Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...